Results 1 to 10 of about 310,786 (327)
Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy
Adoptive cellular immunotherapy harnessing the intrinsic immune system for precise treatment has exhibited preliminary success against malignant tumors.
Yicheng Zhu +4 more
doaj +2 more sources
The review highlights current approaches to adoptive immunotherapy in patients with malignant neoplasms of the female reproductive system.In spite of the obvious advances made by scientists of the world in treating malignant neoplasms, the existing ...
A. N. Gritsai +3 more
doaj +2 more sources
Generation and application of human induced‐stem cell memory T cells for adoptive immunotherapy [PDF]
Adoptive T‐cell therapy is an effective strategy for cancer immunotherapy. However, infused T cells frequently become functionally exhausted, and consequently offer a poor prognosis after transplantation into patients.
Taisuke Kondo +10 more
openalex +2 more sources
Adoptive T Cell Immunotherapy for Cancer [PDF]
Harnessing the immune system to recognize and destroy tumor cells has been the central goal of anti-cancer immunotherapy. In recent years, there has been an increased interest in optimizing this technology in order to make it a clinically feasible ...
Karlo Perica +3 more
doaj +3 more sources
Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies
A significant proportion of hematological malignancies remain limited in treatment options. Immune system modulation serves as a promising therapeutic approach to eliminate malignant cells.
Baixin Ye +7 more
doaj +2 more sources
Adoptive T cell therapy has emerged as a powerful strategy to treat human cancers especially haematological malignancies. Extension of these therapies to solid cancers remains a significant challenge especially in the context of defining immunological ...
Corey Smith +20 more
doaj +2 more sources
Adoptive immunotherapy against ovarian cancer [PDF]
The standard front-line therapy for epithelial ovarian cancer (EOC) is combination of debulking surgery and platinum-based chemotherapy. Nevertheless, the majority of patients experience disease recurrence. Although extensive efforts to find new therapeutic options, cancer cells invariably develop drug resistance and disease progression.
MITTICA, Gloria +6 more
openaire +3 more sources
Adoptive cell transfer as personalized immunotherapy for human cancer [PDF]
Steven A. Rosenberg, Nicholas P. Restifo
openalex +2 more sources
Clinical Study on the Medical Value of Combination Therapy Involving Adoptive Immunotherapy and Chemotherapy for Stage IV Colorectal Cancer (COMVI Study) [PDF]
Yoichiro Yoshida +13 more
openalex +2 more sources

